Sunshine Act Meeting, 51877 [2017-24361]

Download as PDF Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51877 2018 Established quotas (g) Basic class Methamphetamine ............................................................................................................................................................................... 1,446,754 [846,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 564,000 grams for methamphetamine mostly for conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)] Methylphenidate ................................................................................................................................................................................... Morphine (for conversion) .................................................................................................................................................................... Morphine (for sale) .............................................................................................................................................................................. Nabilone ............................................................................................................................................................................................... Noroxymorphone (for conversion) ....................................................................................................................................................... Noroxymorphone (for sale) .................................................................................................................................................................. Opium (powder) ................................................................................................................................................................................... Opium (tincture) ................................................................................................................................................................................... Oripavine .............................................................................................................................................................................................. Oxycodone (for conversion) ................................................................................................................................................................ Oxycodone (for sale) ........................................................................................................................................................................... Oxymorphone (for conversion) ............................................................................................................................................................ Oxymorphone (for sale) ....................................................................................................................................................................... Pentobarbital ........................................................................................................................................................................................ Phenazocine ........................................................................................................................................................................................ Phencyclidine ....................................................................................................................................................................................... Phenmetrazine ..................................................................................................................................................................................... Phenylacetone ..................................................................................................................................................................................... Racemethorphan ................................................................................................................................................................................. Racemorphan ...................................................................................................................................................................................... Remifentanil ......................................................................................................................................................................................... Secobarbital ......................................................................................................................................................................................... Sufentanil ............................................................................................................................................................................................. Tapentadol ........................................................................................................................................................................................... Thebaine .............................................................................................................................................................................................. 64,600,000 4,089,000 33,958,440 31,000 14,044,540 376,000 84,600 564,000 24,534,000 2,453,400 95,692,000 20,962,000 3,395,280 25,850,000 5 35 25 40 5 5 2,820 161,682 1,880 18,388,280 94,000,000 List I Chemicals Ephedrine (for conversion) .................................................................................................................................................................. Ephedrine (for sale) ............................................................................................................................................................................. Phenylpropanolamine (for conversion) ................................................................................................................................................ Phenylpropanolamine (for sale) ........................................................................................................................................................... Pseudoephedrine (for conversion) ...................................................................................................................................................... Pseudoephedrine (for sale) ................................................................................................................................................................. The Administrator also establishes aggregate production quotas for all other schedule I and II controlled substances included in 21 CFR 1308.11 and 1308.12 at zero. In accordance with 21 CFR 1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, the Administrator may adjust the 2018 aggregate production quotas and assessment of annual needs as needed. Dated: November 1, 2017. Robert W. Patterson, Acting Administrator. [FR Doc. 2017–24306 Filed 11–7–17; 8:45 am] ethrower on DSK3G9T082PROD with NOTICES BILLING CODE 4410–09–P VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 600 E Street NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616–6975. DEPARTMENT OF JUSTICE Foreign Claims Settlement Commission [F.C.S.C. Meeting and Hearing Notice No. 10–17] Sunshine Act Meeting Frm 00077 Fmt 4703 Sfmt 4703 Brian M. Simkin, Chief Counsel. [FR Doc. 2017–24361 Filed 11–6–17; 8:45 am] BILLING CODE 4410–BA–P The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR part 503.25) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of open meetings as follows: THURSDAY, NOVEMBER 16, 2017: 10:00 a.m.—Issuance of Proposed Decisions in claims against Iraq. STATUS: Open. All meetings are held at the Foreign Claims Settlement Commission, 600 E Street NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, may be directed to: Patricia M. Hall, Foreign Claims Settlement Commission, PO 00000 47,000 4,136,000 14,100,000 7,990,000 40 180,000,000 DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Clean Air Act On October 31, 2017, the Department of Justice lodged a proposed consent decree with the United States District Court for the District of Colorado in the lawsuit entitled United States of America and the State of Colorado v. PDC Energy, Inc., Civil Action No. 1:17– cv–01552–MSK–MJW. The lawsuit seeks injunctive relief and civil penalties for violations of the Clean Air Act, the Colorado Air E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)]
[Notices]
[Page 51877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24361]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Foreign Claims Settlement Commission

[F.C.S.C. Meeting and Hearing Notice No. 10-17]


Sunshine Act Meeting

    The Foreign Claims Settlement Commission, pursuant to its 
regulations (45 CFR part 503.25) and the Government in the Sunshine Act 
(5 U.S.C. 552b), hereby gives notice in regard to the scheduling of 
open meetings as follows:

Thursday, November 16, 2017: 10:00 a.m.--Issuance of Proposed Decisions 
in claims against Iraq.

Status: Open.
    All meetings are held at the Foreign Claims Settlement Commission, 
600 E Street NW., Washington, DC. Requests for information, or advance 
notices of intention to observe an open meeting, may be directed to: 
Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street 
NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616-6975.

Brian M. Simkin,
Chief Counsel.
[FR Doc. 2017-24361 Filed 11-6-17; 8:45 am]
BILLING CODE 4410-BA-P